Xtx Topco LTD Nls Pharmaceutics Ltd. Transaction History
Xtx Topco LTD
- $710 Million
- Q1 2024
A detailed history of Xtx Topco LTD transactions in Nls Pharmaceutics Ltd. stock. As of the latest transaction made, Xtx Topco LTD holds 25,594 shares of NLSP stock, worth $5,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,594Holding current value
$5,118% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NLSP
# of Institutions
9Shares Held
8.16MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA5.75MShares$1.15 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY2.17MShares$434,4000.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny180KShares$35,9150.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il19.2KShares$3,8360.0% of portfolio
-
Geode Capital Management, LLC Boston, MA14.4KShares$2,8720.0% of portfolio
About NLS Pharmaceutics Ltd.
- Ticker NLSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,349,900
- Market Cap $5.87M
- Description
- NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...